Central Nervous System–Specific Outcomes of Phase 3 Randomized Clinical Trials in Patients With Advanced Breast Cancer, Lung Cancer, and Melanoma Journal Articles

Overview
Research
Identity
Additional Document Info
View All

abstract

This cohort study determines the proportion of phase 3 clinical trials for patients with metastatic breast cancer, lung cancer, and melanoma that included patients with brain metastases and/or evaluated central nervous system–specific end points.

authors

Corbett, Kathryn
Sharma, Alisha
Pond, Gregory
Brastianos, Priscilla K
Das, Sunit
Sahgal, Arjun
Jerzak, Katarzyna J

status

published

publication date

July 1, 2021

has subject area

1112 Oncology and Carcinogenesis (FoR)
1117 Public Health and Health Services (FoR)
Breast Neoplasms (MeSH)
Central Nervous System (MeSH)
Clinical Trials, Phase III as Topic (MeSH)
Female (MeSH)
Humans (MeSH)
Lung Neoplasms (MeSH)
Melanoma (MeSH)
Randomized Controlled Trials as Topic (MeSH)

published in

JAMA Oncology Journal